Fundraising FoxNippon Venture Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
InterCure produces, manufactures, and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use in licensed markets including Israel, the European Union, and Australia, and operates a chain of over 25 licensed pharmacies across Israel, the UK, and Austria that specialize in medical cannabis dispensing.
BiotechHertzliya
Alexander Rabinovich(Executive Officer, Director)Amos Cohen(Chief Financial Officer)inBarak Cohenin
BoardDavid Salton(Director)Lennie Michelson Grinbaum(Director)Gideon Hirschfeld(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.